ObsEva Reports Second Quarter 2019 Financial Results

GENEVA, Switzerland and BOSTON, MA (August 7, 2019) ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a womans reproductive health and pregnancy, today reported financial results for the second quarter ending June 30, 2019 and provided a business update.